Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3686
Source ID: NCT05331469
Associated Drug: Nph Basal Insulin Titration
Title: Difference of Basal Insulin Titration Method in Reducing HbA1c Among Type 2 Diabetes Mellitus (T2DM) Patients.
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c and Have Lesser Hypoglycemia
Interventions: DRUG: NPH basal insulin titration
Outcome Measures: Primary: Hba1c reduction, To compare the HbA1c reduction of the daily basal insulin titration arm with the 3-daily basal insulin titration arm, 3 months | Secondary: percentage of subjects achieving fasting capillary blood glucose and/or hba1c below 7%, To compare the percentage of patient achieving fasting blood glucose within 4.4-7mmol/L and/or HbA1c below 7% between the daily basal insulin titration arm with the 3-daily basal insulin titration arm within the study period, 3 months|Hypoglycemia frequency, To compare the frequency of hypoglycemia between the daily basal insulin titration arm with the 3- daily basal insulin titration arm, 3 months|Basal insulin required to achieve fasting blood sugar less than 7mmol/L, To compare the total basal insulin dosage required to achieve normal fasting CBG 4.4-7.0mmol/L between the daily basal insulin titration arm with the 3-daily basal insulin titration arm, 3 months|Duration to achieve fasting cappilary blood glucose less than 7mmol/L, To compare the duration taken to achieve normal fasting CBG 4.4-7.0mmol/L between the daily basal insulin titration arm with the 3-daily basal insulin titration arm, 3 months|Satisfaction of titration, To compare the satisfaction to the titration method between the daily basal insulin titration arm with the 3-daily basal insulin titration arm, 3 months|Weight changes after intervention, To compare with weight changed between the daily basal insulin titration arm with the 3-daily basal insulin titration arm, 3 months
Sponsor/Collaborators: Sponsor: University of Malaya
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 70
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2021-07-19
Completion Date: 2023-04-30
Results First Posted:
Last Update Posted: 2022-04-15
Locations: University Malaya Medical Centre, Kuala Lumpur, Malaysia
URL: https://clinicaltrials.gov/show/NCT05331469